 Pukrečil? Ja bili, že človek je tudi vznikil in vznikil na vse model. Tudi je veliko manječka in anatomija. Kaj je tudi jev, laj, artificial... ...artificiali in vene, ki se svoje iznojimo v laži, ...vznikil smo vznikil, kaj je to vznikil, ...zato je veliko vznikil in vznikil. Tega da je to nekaj nekaj nekaj čnij? Vževljno, lahko je lačen mese brain, tko priživaj Sandmanov v Karnike, znišljamo vičovovskii bil, da očastim vaskulir vsega vsega, bo jo neko vaskulir, in 70 per cent v tem različenih, je to izgleda na vene z vsej ležnih. Vsej, vsej, je izgleda na več milijonov taj vsej operacij, in vsej ležnih izgleda na vsej ležnih je tudi, da 10-15 per cent vsej ležnih vsej ležnih izgleda na več mene. In after ten anos more than 50% of them will be blocked. So while we are doing and we actually achieve good benefit for patients, we feel that those are suboptimal and that if we came up with vessels that are resembling more arterial type of features then we could prolong those benefits. This is because on the clinical experience, we learned that when you use artery, which we also use bip Lamborghini, they last much longer like for example 20 years or so. What are you hoping to replace these blood vessels with? What you other to use? Where are studying different configurations of scaffold stem cells and drugs Zelo v Vittro, v bioreaktorji, statičnih in dinamikstv, vzvečaj, ki so, če je to, da je tudi izvah, je, da bi testi vzvečenih, vzvečenih, eksperimentih modelov, ki je jazeljne, in tudi človek, anatomijski in immunologijno. the stage you are at is very much student development, where your artificial blood vessel has to be tested in a live animal, see how it responds to the stresses of a live animal. Implant it with the same technique that you would use into a patient, so the same surgery, the same setting, and then absolutely right, see how the graft responds to the dynamic stress, ali če si na vse občiji čutim neseljno, in je to zelo, da je to zelo površenje. In površenje, da je to čutim, da je tudi površenje površenje, če ni površenje, da je to za površenje, da je to za površenje, zelo je to zelo, da je zelo, da je zašeljno vse interfejst v teh materijali in načine. in kako imunoločno zelo Ali Marlo, ki je nekaj nekaj, je zelo vsega. If you didn't have access to animals to work on, would you be able to progress this work by testing on humans? That's a very interesting question, and the answer is, obviously coming from the clinical world, I think the answer is to be very difficult, if not impossible, because no matter how good they can be, but in vitro models or non-in vivo models, like mechanical or artificial type of settings, can never account for all the combination of factors that you face when an implant is done in proper models. And we're talking about basically an arterial implant with a diameter of like 4, 5, 6 mm for length of 3 or 4 cm. This is for the bypass graft we are working on right now. Really, to do an operation in a setting that is almost resembling what we do in NHS with a large team of people, all to make sure that one single operation is done properly with the right level of clinical expertise, academic expertise, but also with the right level of sensitivity and humanity is so important.